scispace - formally typeset
A

Amir Amiri-Sadeghan

Researcher at Tabriz University of Medical Sciences

Publications -  9
Citations -  38

Amir Amiri-Sadeghan is an academic researcher from Tabriz University of Medical Sciences. The author has contributed to research in topics: Biology & Gene. The author has an hindex of 2, co-authored 4 publications receiving 13 citations. Previous affiliations of Amir Amiri-Sadeghan include University of Tabriz.

Papers
More filters
Journal ArticleDOI

Long non-coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis.

TL;DR: In this paper, the authors used the LncTarD web tool to identify the target genes and regulatory mechanisms of the selected lncRNAs and found that each group of target genes controls 50, 12, 7, and 2 molecular pathways, respectively.
Journal ArticleDOI

Association of NOS3-c.894G>T transversion with susceptibility to metabolic syndrome in Azar-cohort population: A case-control study and in silico analysis of the SNP molecular effects.

TL;DR: In silico investigation revealed that c.894G>T may alter eNOS function through affecting interactions of its oxygenase domain with proteins such as B2R, b-actin, CALM1, CAV1, GIT1, HSP90AA1, NOSIP, and NOSTRIN.
Journal ArticleDOI

An introduction to EpiPol (Epigenetic affecting Polymorphism) concept with an in silico identification of CpG-affecting SNPs in the upstream regulatory sequences of human AHR gene

TL;DR: The EpiPol concept is introduced, which abbreviates the epigenetic affecting polymorphism and describes those variations in the regulatory sequences of a gene, which may affect epigenetic regulations of its expression, as well as predicted methylation-affecting Epi Pols of the human AHR gene.
Journal ArticleDOI

A Review of Substrates for Solid-State Fermentation of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), for Basidiome Production and Effect on Bioactive Compounds.

TL;DR: It is concluded that future research focused on various treatments to modulate extracellular enzyme production may bring more options to the table for innovative solid substrate formulation.